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1 Background
The FetchProt Corpus has been built within the FetchProt project1 in order to work as training 
and test data for the FetchProt system. The project, a collaboration between Swedish Institute 
of Computer Science (SICS), Center for Genomics and Bioinformatics (CGB) at Karolinska 
Institutet  and  the  company  Metamatrix  AB,  receives  partial  funding  from  The  Swedish 
Agency for Innovation Systems – VINNOVA, from November 2003 to November 2006. The 
aim is to build a system that automatically searches full text scientific articles and identifies 
proteins for which the function has been experimentally verified.  The system is  to aid in 
populating the EXProt database (Ursing et al., 2002) 2.
Since the scope of  covering all protein functions is too big, we start by looking at tyrosine 
kinase as described in Gene Ontology3 GO:000471 (see also GO:0004714, transmembrane 
receptor  protein  tyrosine  kinase  activity;  GO:0004715,  non-membrane  spanning  protein 
tyrosine kinase activity; GO:0004718, Janus kinase activity). 
Experiments that verify the tyrosine kinase activity are listed in  (p. 12). In a first instance the 
goal will be to identify proteins that have undergone one or more of these experiments. 
2 Description of the corpus (version 1.0)
The corpus consists of published journal articles freely available on the internet. Most of the 
selected articles describe experiments on proteins verifying tyrosine kinase activity, but we 
have also included, as potential  false positives, articles that do not have instances of such 
experiments. 
The corpus consists of 200 full text scientific articles.
• 150 of the articles include descriptions of experiments that verify tyrosine kinase 
activity.
• 50 of the articles do not include such descriptions.
• Both sets contain articles from approximately the same set of journals (Table 1 p. 7.)
• All articles are freely available for anyone to download from the Internet.
• All articles are available on the internet both as PDF-files and in html-versions.
• 771 experiments and 771 results are tagged in the corpus.
• 273 wild types and 92 different mutations of 77 proteins with UNIPROT IDs and 48 
proteins without UNIPROT IDs, are subject to experimental validation of tyrosine 
kinase activity. 
• The sentences describing the experiments and their result are tagged, as well as the 
proteins involved in the experiments, their cell line, species, and mutant description.
2.1 Files
Each journal article is represented by 2 text files in the corpus:
1 http://fetchprot.sics.se/
2 http://nar.oupjournals.org/cgi/reprint/30/1/50.pdf 
3 http://www.geneontology.org/ontology/function.ontology
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The template file is the xml-file containing a structured template filled with the information 
annotated for the corresponding article (see 2.3). This file is to be used as a key when evalua-
ting models. 
The annotated text file is a file with the content of the article in plain text interspersed with 
annotations (xml-style tags) surrounding specific semantic elements (see semantic definitions 
under Tags and their use below) in the text. This file is a reference to where in the files the 
text in the filled templates is to be found for every annotation. 
The  text  files  have been produced by saving  the  PDF-files  as  text  using Adobe Acrobat 
Reader v. 6.0.0. This is not an ideal solution, since every way of converting PDF-files to text 
result in a loss of information. We found that this version of Acrobat Reader provided the best 
conversion, but it still resulted in corrupt text files. All Greek letters and most mathematical 
symbols have received incorrect representations and their identity cannot be retraced since 
they are not converted in a consistent manner. In this version of the corpus we have checked 
by hand all text between tags  against the original files and transformed every character that 
was not converted correctly by Acrobat Reader into a corresponding numeric character refe-
rence code (cf.  Table 5, page  13). The main purpose of the annotated text  file  is  thus to 
function as a reference file for the corresponding template file, not to be the canonical text 
version of the PDF version of the article.  In the next  release we plan to complement  the 
corpus with text versions derived from the html versions of the articles. 
The journal articles were chosen by posing search queries against PubMed4. For a list of the 
queries used, see Table 2. For a list of documents in the corpus for each query c.f. Table 6.
The corpus is downloadable from the FetchProt homepage: http://fetchprot.sics.se/
2.2 The analysis
This is a narrative description of the analysis of the corpus. For a structured description, see 
2.3 (Example template) and Figure 1 (Document Type Definition). The focus of the analysis 
of the corpus is the mentioning of proteins with an experimentally verified tyrosine kinase 
activity. This is mirrored in that the main entity in the analysis is the specific mutant or wild 
type  of  a  protein.  For  each  protein,  the  function  slot(s)  in  the  template  file  consists  of 
evidence slot(s)  consisting of  experiment and  result slots  that  are  filled with the sentence 
instances from the article. For  experiment  and  result, the sentence is the minimum level of 
analysis. The experiments belong to one of the categories listed in  (p.  12). The function(s), 
the  evidence(s),  the  experiment(s),  the  result(s)  and  the  rest  of  the information  about  the 
protein are connected to the specific protein mutant and to each other via identity values in the 
tags (prid, fun_id, ev_id).
The templates also include information that is not explicit in the articles (and therefore not 
tagged in the annotated text  files).  Some of the information in the template  file  has been 
inferred from common knowledge and some has been derived from other external knowledge 
sources. Examples of the first case are when <mutant_desc> (mutant description) has been set to 
“wild type” based on the lack of specification of a mutant, and when the <species> has been 
established from the name of the <cell_line>. Examples of the latter are <pubmed_id>, <url>, 
<wt_uniprot_id>  (wild type protein UniProt identity code),  <wt_ec_number> (wild type 
protein EC number), and the go_id (Gene Ontology molecular function identity code) feature 
in the <function> tag.
4 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
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2.3 Template structure - Example template
<?xml version="1.0" encoding="ISO-8859-1" ?>
<!DOCTYPE doc SYSTEM "template01.dtd">
<doc>
<authors>Masahiro Tsuda, Takashi Matozaki, Kaoru Fukunaga, Yohsuke Fujioka, Akira Imamoto, 
Tetsuya Noguchi, Toshiyuki Takada, Takuji Yamao, Hitoshi Takeda, Fukashi Ochi, Tadashi 
Yamamoto, and Masato Kasuga</authors>
  <title>Integrin-mediated Tyrosine Phosphorylation of SHPS-1 and Its Association with SHP-2 
  ROLES OF Fak AND Src FAMILY KINASES</title>
  <journal>THE JOURNAL OF BIOLOGICAL CHEMISTRY</journal>
  <year>1998</year>
  <volume>273</volume>
  <pages>13223-13229</pages>
  <pubmed_id>9582366</pubmed_id>
  <url>http://www.jbc.org/cgi/reprint/273/21/13223</url>
  <protein prid="p1">
         <wt_uniprot_id prid="p1">Q9WUD9</wt_uniprot_id>
         <wt_ec_number prid="p1">2.7.1.112</wt_ec_number>
         <protein_name prid="p1">Src</protein_name>
         <organism prid="p1">
      <species prid="p1">Rat-1</species>
      <mutant_desc prid="p1">wild-type</mutant_desc>
      <cell_type prid="p1">fibroblasts</cell_type>
         </organism>
         <function prid="p1" fun_id="f1" go_id="GO:0004715">
      <evidence prid="p1" fun_id="f1" ev_id="e1" type="006">
<experiment prid="p1" fun_id="f1" ev_id="e1">We next examined whether Src or 
Fak catalyze the tyrosine phosphorylation of SHPS-1 in vitro. Incubation of a GST 
fusion protein containing the cytoplasmic domain of SHPS-1 (GST-SHPS-1-cyto) with 
Src kinase immunoprecipitated from Rat-1 cells resulted in the phosphorylation of both 
GST-SHPS-1-cyto (Fig. 5A) and Src (Fig. 5C).</experiment>
<result prid="p1" fun_id="f1" ev_id="e1">Incubation of a GST fusion protein 
containing the cytoplasmic domain of SHPS-1 (GST-SHPS-1-cyto) with Src kinase 
immunoprecipitated from Rat-1 cells resulted in the phosphorylation of both GST-
SHPS-1-cyto (Fig. 5A) and Src (Fig. 5C).</result>
      </evidence>
         </function>
  </protein>
  <protein prid="p2">
         <wt_uniprot_id prid="p2">P34152</wt_uniprot_id>
         <wt_ec_number prid="p2">2.7.1.112</wt_ec_number>
         <protein_name prid="p2">Fak</protein_name>
         <organism prid="p2">
      <species prid="p2">mouse</species>
      <mutant_desc prid="p2">wild-type</mutant_desc>
         </organism>
         <function prid="p2" fun_id="f2" go_id="GO:0004715">
      <evidence prid="p2" fun_id="f2" ev_id="e2" type="006">
<experiment prid="p2" fun_id="f2" ev_id="e2">In contrast, HA-tagged Fak 
immunoprecipitated from transfected COS-7 cells with antibodies to HA catalyzed the 
phosphorylation of poly(Glu, Tyr) (Fig. 5A) and Fak (Fig. 5B), but not that of GST-
SHPS-1-cyto (Fig. 5A).</experiment>
<result prid="p2" fun_id="f2" ev_id="e2">In contrast, HA-tagged Fak 
immunoprecipitated from transfected COS-7 cells with antibodies to HA catalyzed the 
phosphorylation of poly(Glu, Tyr) (Fig. 5A) and Fak (Fig. 5B), but not that of GST-
SHPS-1-cyto (Fig. 5A).</result>
      </evidence>
         </function>
  </protein>
</doc>
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Table 1 Journal names, abbreviations, and number of relevant and irrelevant articles for each journal.
Journal name File name starts with … Rel. Irrel
.
American Journal of Physiology – Renal Physiology AmericanJournalOfPhysiology 1
American Journal of Physiology – Cell Physiology AJP-CellPhysiology 1
Biochemical Journal Biochem_J 1 1
Biology of Reproduction BiologyOfReproduction 1
Blood Blood 5 4
Cancer Research CancerResearch 1
Cell Death and Differentiation CellDeathAndDifferentiation 1
Cell Growth & Differentiation CellGrowth&Differentiation 4 1
Circulation Research CirculationResearch 2 1
Clinical Cancer Research ClinicalCancerResearch 1 1
Diabetes Diabetes 1 1
Endocrinology Endocrinology 4 1
European Journal of Biochemistry EuropeanJournalOfBiochemistry 4 1
Genes & Development Genes&Development 1
Journal of Applied Physiology JournalOfAppliedPhysiology 1
The Journal of Biological Chemistry JBC 78 24
Journal of Bacteriology JBacteriology 1(108)
The Journal of Cell Biology JCB 2 1
The Journal of Clinical Investigation JCI 2 1
The Journal of Clinical Endocrinology & Metabolism JClinEndocrinology&Metabolism 2
The Journal of Experimental Medicine JournalOfExperimentalMedicine 1
Journal of General Virology JournalOfGeneralVirology 1
Journal of Neurophysiology JNeurophysiol 1
Molecular Biology of the Cell MBC 2
Molecular Cancer Research MolecularCancerResearch 1
Molecular and Cellular Biology MCB 5 2
Molecular Endocrinology MolecularEndocrinology 2 1
Proceedings of the National Academy of Sciences of the 
United States of America
PNAS 7 3
The American Journal of Pathology TheAmericanJournalOfPathology 2
The Journal of Immunology TheJournalOfImmunology 12 4
The Journal of Neuroscience TheJournalOfNeuroscience 1 1
The Journal of Pharmacology and Experimental 
Therapeutics
TheJPETherapeutics 2 1
Sum 150 50
7
Table 2 Queries used to find relevant and irrelevant articles, number of included papers from each group.
Query Relevant papers Irrelevant papers
alk in vitro 2 1
csk in vitro 5 2
egfr phosphorylation in vitro 1
fak1 in vitro phosphorylation 1
fes in vitro 2 1
fgr in vitro 3 1
fyn in vitro 13 6
hck in vitro 5
insulin receptor phosphorylation in vitro 11
jak1 in vitro 3 1
jak2 in vitro 7 3
jak3 in vitro 1 4
kns1 in vitro 1
lck in vitro 10 3
lyn in vitro 4 1
platelet derived growth factor receptor in vitro 4
pyk2 in vitro phosphorylation 4
src in vitro phosphorylate 5
syk in vitro 8 2
tyk2 in vitro 1
tyrosine kinase activity substrate km 9 6
tyrosine kinase direct substrate 2 9
tyrosine kinase km substrate 1 1
tyrosine kinase substrate in vitro direct 14 3
tyrosine kinase substrate vitro kinetics 6
tyrosine kinase vitro substrate activity 2
tyrosine kinase vitro substrate kcat 1
tyrosine kinase vitro substrate novel 2
tyrosine phosphorylation in vitro 2
tyrosine phosphorylation substrate in vitro 11 4
txk in vitro 1
zap-70 in vitro 1 1
yes in vitro 1
Unknown query 7
Sum 150 50
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3 Annotation Manual
The following instructions have guided the annotator in his work.
• The annotation scheme for the template files follows xml standard.
• The annotated text documents use xml tags, but are not valid xml documents.
• The text that fills the template is the ideal version of the text between tags in the anno-
tated text file. For example, signs for affiliation are removed in the template, and text 
from figures and tables that show up in the middle of the text due to bad conversion, is 
not to be transferred to the template.  The template  file is the key with the correct 
answer to the information need.
• Tags must not be interlaced, i.e <a><b>hh</a></b> should be <a><b>xx</b></a>
• Under experiment and result 
o Each tagged area consists of at least one full sentences (including period, ”.”), 
but can consist of several consecutive sentences
o The sentence(s) between experiment tags should state which experiment has 
been performed and, if possible, the expected achievement by doing this (e.g.: 
In order to verify X we performed Y)
o Only sentences describing relevant and important information is to be tagged
o A sentence can have more than one tag e.g. 
<experiment prid=”p1” ev_id=”e1” type=”001”><result prid=”p1” 
ev_id=”e1”>In order to verify X we performed Y and found that  
<protein_name prid=”p1”>protein Z</protein_name> had function  
W.</result></experiment>
o Consecutive sentences to be included in an experiment or result annotation 
should be inside the same tags
o Sentences referring to experiments or results belonging to the same evidence 
should have the same id
• Only use papers that exist both in PDF and HTML format.
Table 3 Tags and their use.
Typ of tag Mandatory 
in template
Tag if in 
article
Description
<doc>     * Beginning and end of template. Only one template per 
article.
<authors> * * All authors of the article as in the article. In the template, 
numbers or signs for affiliation are removed. 
<title> * * Full title of article. In the template, referencing numbers 
or signs are removed.
<journal> * * Full journal name or abbreviation according to PubMed 
or as in paper.
<year> * * Year of publication with 4 characters.
<volume> * * Journal volume.
<pages> * * Full page reference start page - end page, full page 
numbering (NOT 123-5).
<pubmed_id> * Pubmed id.
<url> * URL of full text article in pdf.
<protein prid=”p1”> * Beginning of description of protein 1 with identity 
feature (prid=”p1”) 
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<wt_uniprot_id 
prid=”p1”>
Reference to amino acid sequence database (UNIPROT) 
for the wild type of the protein. If species cannot be 
derived from text, or if there is no suitable UniProt id in 
the database, use UNKNOWN.
<wt_ec_number 
prid=”p1”>
EC number for wild type protein function.
<protein_name 
prid=“p1”>
* * Protein name as stated, and tagged either in evidence or 
the last instance before the evidence (closest to)
<organism prid=”p1”> * Beginning of description of origin of protein.
<species prid="p1"> * * Species origin of protein. Organism name as stated in the 
text, if possible scientific name, but can also be “human”, 
“murine”, “feline” if unambiguous, but not preferred. 
The instance closest before the protein name in the text 
should be tagged. If none before the protein name, the 
closest instance after should be tagged. If text does not 
mention species, use UNKNOWN.
<mutant_desc 
prid=”p1”>
* Mutant description as it is stated in the text. If not 
mutant, “WT” or as described in text (e.g., 
“endogenous”). The instance closest before the protein 
name in the text should be tagged. If none before the 
protein name, the closest instance after should be tagged.
<cell_type prid=”p1”> * Cell type of origin of tagged protein. The instance closest 
before the protein name in the text should be tagged. If 
none before the protein name, the closest instance after 
should be tagged.
<cell_line prid=”p1”> * Cell line of origin of tagged protein. The instance closest 
before the protein name in the text should be tagged. If 
none before the protein name, the closest instance after 
should be tagged.
<function prid=”p1” 
fun_id=”f1” 
go_id=”GO:0004713”>
* Beginning of description of function. Can have many 
evidences. Each function has a unique id – fun_id as 
well as a go_id identifying the molecular function 
according to Gene Ontology.
<evidence prid=”p1” 
ev_id=”e1” fun_id=”f1” 
type="005">
* The evidence element consists of the experiment part 
and the result part. There can only be one experiment 
and one result per evidence. However, there can be more 
than one text instance, describing an experiment or a 
result, per evidence, then describing the same experiment 
or result.
For an evidence annotation, only sentences stating which 
experiment is performed to verify a specific function is to 
be tagged.  
Evidence belonging to the same function should have the 
same fun_id.
Each evidence has a unique id – ev_id.
Attribute type refers to type of evidence according to list 
( p. 12).
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<experiment prid=”p1” 
fun_id=”f1” 
ev_id=”e1”>
* * Describes the experiment in a sentence(s) like “In order 
to test X we performed Y”. There can be more than one 
sentence per tag, but only full sentences. All sentences 
belonging to the same evidence should have the same 
ev_id.
<result prid=”p1” 
fun_id=”f1” 
ev_id=”e1”>
* * Describing the results from the above mentioned 
experiment. Can be more than one sentence. Only full 
sentences. All sentences belonging to the same evidence 
should have the same ev_id.
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Table 4 Evidence types in the corpus. A number of experiments used in verifying tyrosine kinase activity.
Type number Description of evidence
005 PHOSPHOAMINO ANALYSIS
006 KINASE/PHOSPHOTRANSFERASE
024 DENSITOMETRIC ANALYSIS
039 IMMUNOBLOTTING
041 PHOSPHOPEPTIDE MAPPING
042 MASS SPECTROMETRY
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Table 5 Numerical character references used.
Figure 1. The template DTD
<!ELEMENT doc (authors,title,journal,year,volume,pages,pubmed_id,url,protein*)>
<!ELEMENT authors (#PCDATA)>
<!ELEMENT title (#PCDATA)>
<!ELEMENT journal (#PCDATA)>
<!ELEMENT year (#PCDATA)>
<!ELEMENT volume (#PCDATA)>
<!ELEMENT pages (#PCDATA)>
<!ELEMENT pubmed_id (#PCDATA)>
<!ELEMENT url (#PCDATA)>
<!ELEMENT protein (wt_uniprot_id, wt_ec_number, protein_name, organism, function+)>
<!ATTLIST protein prid ID #REQUIRED>
<!ELEMENT wt_uniprot_id (#PCDATA)>
<!ATTLIST wt_uniprot_id prid IDREF #REQUIRED>
<!ELEMENT wt_ec_number (#PCDATA)>
<!ATTLIST wt_ec_number prid IDREF #REQUIRED>
<!ELEMENT protein_name (#PCDATA)>
<!ATTLIST protein_name prid IDREF #REQUIRED>
<!ELEMENT organism (species, mutant_desc, cell_type?,cell_line?)>
<!ATTLIST organism prid IDREF #REQUIRED>
<!ELEMENT species (#PCDATA)>
<!ATTLIST species prid IDREF #REQUIRED>
<!ELEMENT mutant_desc (#PCDATA)>
<!ATTLIST mutant_desc prid IDREF #REQUIRED>
<!ELEMENT cell_type (#PCDATA)>
<!ATTLIST cell_type prid IDREF #REQUIRED>
<!ELEMENT cell_line (#PCDATA)>
<!ATTLIST cell_line prid IDREF #REQUIRED>
<!ELEMENT function (evidence+)>
<!ATTLIST function prid IDREF #REQUIRED>
<!ATTLIST function fun_id ID #REQUIRED>
<!ATTLIST function go_id ID #REQUIRED>
<!ELEMENT evidence (experiment+,result+)>
<!ATTLIST evidence prid IDREF #REQUIRED>
<!ATTLIST evidence fun_id IDREF #REQUIRED>
<!ATTLIST evidence ev_id ID #REQUIRED>
<!ATTLIST evidence type CDATA #REQUIRED>
<!ELEMENT experiment (#PCDATA)>
<!ATTLIST experiment prid IDREF #REQUIRED>
<!ATTLIST experiment fun_id IDREF #REQUIRED>
<!ATTLIST experiment ev_id IDREF #REQUIRED>
<!ELEMENT result (#PCDATA)>
<!ATTLIST result prid IDREF #REQUIRED>
<!ATTLIST result fun_id IDREF #REQUIRED>
<!ATTLIST result ev_id IDREF #REQUIRED>
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Character reference Corresponding 
character
Name Unicode
&#34; " Quotation Mark
&#38; & Ampersand
&#60; < Less Than Sign
&#61; = Equals Sign
&#62; > Greater Than Sign
&#126; ~ Tilde
&#134; (&#8224;) † Dagger \u2020
&#135; (&#8225;) ‡ Double Dagger \u2021
&#149; (&#8226;) • Bullet \u2022
&#176; ° Degree Sign \u00B0
&#177; ± Plus Minus \u00B1
&#916; Δ Capital Delta \u0394
&#936; Ψ Capital Psi \u03A8
&#945; α Small Alpha \u03B1
&#946; β Small Beta \u03B2
&#947; γ Small Gamma \u03B3
&#948; δ Small Delta \u03B4
&#949; ε Small Epsilon \u03B5
&#950; ζ Small Zeta \u03B6
&#952; θ Small Theta \u03B8
&#954; κ Small Kappa \u03BA
&#956; μ Small Mu \u03BC
&#963; σ Small Sigma \u03C3
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Table 6 Relevant and irrelevant articles in the corpus for each PubMed query
Query Relevant articles Irrelevant articles
alk in vitro Blood_96_1605_1607
TheAmericanJournalOfPathology_154_1657_1663
ClinicalCancerResearch_9_1121_1128
csk in vitro JBC_272_1355_1362
JBC_273_10004_10010
JBC_274_2291_2297
JBC_274_5422_5428
JBC_275_29183_29186
JBC_279_5975_5983
JBC_271_14989_14994
egfr 
phosphorylation in 
vitro
 JBC_278_37413_37418
fak1 in vitro 
phosphorylation
 MolecularEndocrinology_16_1612_1628
fes in vitro  CellGrowth&Differentiation_11_581_592
 MCB_19_8335_8343
Blood_103_912_920
fgr in vitro JBC_275_41124_41132
TheJournalOfImmunology_172_5034_5040
AJP-CellPhysiology_281_C1385_C1395
PNAS_95_7580_7584
fyn in vitro EuropeanJournalOfBiochemistry_271_2615_2623
Genes&Development_13_2400_2411
JBC_273_13223_13229
JBC_274_5522_5531
JBC_276_3879_3884
JBC_276_693_699
JBC_277_6775_6778
JCB_149_423_430
PNAS_96_2461_2466
TheJournalOfImmunology_162_7224_7232
TheJournalOfNeuroscience_21_3606_3618
TheJPETherapeutics_303_1325_1333
JBC_276_42389_42400
JBC_277_21561_21566
JBC_278_31574_31583.
JBC_278_5894_5901
JCB_155_447_458
CirculationResearch_91_953_960
Jneurophysiol_79_137_142
hck in vitro Blood_101_690_698
JBC_274_26579_26583
JBC_275_33353_33364
JournalOfGeneralVirology_85_721_729
JBC_276_25605_25611
insulin receptor 
phosphorylation in 
vitro
JBC_277_10698_10703
JClinEndocrinology&Metabolism_89_4678_4684
JournalOfAppliedPhysiology_91_2240_2247
JBC_278_27896_27902
Endocrinology_140_55_62
JBC_273_26962_26968
JBC_273_31890_31900
TheJPETherapeutics_286_569_577
Endocrinology_139_520_526
Endocrinology_139_884_893
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Query Relevant articles Irrelevant articles
JBC_271_7134_7140
jak1 in vitro  JBC_273_25510_25515
 JBC_274_20818_20825
 JBC_274_9587_9599
Blood_101_4937_4943
jak2 in vitro JBC_274_35492_35498
JBC_275_34719_34727
JBC_278_11970_11978
MCB_24_4955_4967
MolecularEndocrinology_17_2268_2282
TheJournalOfImmunology_164_4575_4585
TheJournalOfImmunology_165_2116_2123
JBC_279_44460_44466
MolecularEndocrinology_18_1471_1485
JBC_278_46171_46178
jak3 in vitro TheJournalOfImmunology_160_2042_2045 TheJournalOfImmunology_166_3724_3732
TheJPETherapeutics_295_912_926
JBC_274_30266_30272
JBC_277_28830_28835
kns1 in vitro JBC_271_27299_27303
lck in vitro CirculationResearch_85_12_22
EuropeanJournalOfBiochemistry_270_2369_2376
JBC_274_20056_20059
JBC_275_1685_1690
JBC_276_17455_17460
JBC_277_4999_5007
JournalOfExperimentalMedicine_193_497_507
PNAS_98_6587_6592
TheJournalOfImmunology_168_1978_1983
MolecularCancerResearch_1_155_163
JBC_279_2937_2944.
Blood_103_1002_1010.
JBC_278_34854_34863
lyn in vitro Blood_98_3121_3127
JBC_276_33282_33290
TheJournalOfImmunology_167_6394_6402
TheJournalOfImmunology_163_1321_1326
PNAS_97_6687_6692
platelet derived 
growth factor 
receptor in vitro
Biochem_J_327_139_145
AmericanJournalOfPathology_163_277_286
JBC_277_15499_15506
JBC_279_19732_19738
pyk2 in vitro 
phosphorylation
AmericanJournalOfPhysiology_275_F447_F451
JBC_274_29196_29201
JBC_274_31261_31271
JBC_277_45203_45210
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Query Relevant articles Irrelevant articles
src in vitro 
phosphorylate
Blood_91_3734_3745
JBC_273_17186_17191
JBC_274_6285_6294
TheJournalOfImmunology_160_1647_1658
MCB_24_2573_2583
syk in vitro CellGrowth&Differentiation_12_193_200
ClinicalCancerResearch_5_4264_4272
JBC_275_35442_35447
JBC_276_38595_38601
JBC_276_47982_47992
PNAS_96_11976_11981
TheJournalOfImmunology_165_1344_1351
TheJournalOfImmunology_172_4486_4492
PNAS_101_6158_6163
TheJournalOfImmunology_169_1028_1036
txk in vitro JBC__277_755_762
tyk2 in vitro TheJournalOfImmunology_171_2989_2994
tyrosine kinase 
activity substrate 
km
JBacteriology_186_3472_3479
JBC_278_17328_17335
JBC_278_24072_24077
JBC_278_39323_39329
JCB_165_493_503
JClinEndocrinology&Metabolism_88_1323_1332
PNAS_100_14707_14712
PNAS_102_7109_7114
CellGrowth&Differentiation_12_379_386
Diabetes_54_361_366
JBC_279_55348_55354
JBC_279_52500_52516
Biochem_J_385_737_744
JBC_279_44039_44045
EuropeanJournalOfBiochemistry_270_3891_3903
tyrosine kinase 
direct substrate
PNAS_100_13298_13302
EuropeanJournalOfBiochemistry_268_4158_4168
Blood_102_659_661
Endocrinology_144_2988_2996
JBC_274_27610_27616
JBC_276_42932_42937
JBC_279_33759_33767
JBC_279_49523_49532
MCB_23_6255_6266
MCB_23_7510_7524
TheJournalOfImmunology_172_331_339
tyrosine kinase 
km substrate
 MCB_24_10558_10572 CellGrowth&Differentiation_10_805_812
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Query Relevant articles Irrelevant articles
tyrosine kinase 
substrate in vitro 
direct
Endocrinology_141_621_628
JBC_273_16756_16763
JBC_274_19003_19010
JBC_276_17339_17346
JBC_276_28006_28013
JBC_276_42843_42850
JBC_277_21537_21541
JBC_277_9422_9428
JCI_101_2751_2760
JCI_99_1831_1841
MCB_21_7641_7652
PNAS_94_2295_2300
JBC_274_22151_22154
JBC_278_13740_13746
JBC_278_34854_34863
JBC_277_13620_13627
JBC_276_37747_37753
tyrosine kinase 
substrate vitro 
kinetics
JBC_270_29773_29780
JBC_270_30829_30836
JBC_271_15753_15761
JBC_271_4755_4762
JBC_271_7465_7472
JBC_274_7557_7564
tyrosine kinase 
vitro substrate 
activity
BiologyOfRreproduction_67_301_307
MBC_14_1448_1459
tyrosine kinase 
vitro substrate 
kcat
JBC_270_27112_27115
tyrosine kinase 
vitro substrate 
novel
Diabetes_50_824_830
JBC_278_47610_47621
tyrosine 
phosphorylation in 
vitro
JBC_279_55827_55832
CellGrowth&Differentiation_10_387_396
tyrosine 
phosphorylation 
substrate in vitro
CancerResearch_61_8887_8895
CellDeathAndDifferentiation_11_290_300
EuropeanJournalOfBiochemistry_266_1166_1173
JBC_274_33123_33130
JBC_275_41439_41446
JBC_276_16885_16893
JBC_276_47966_47974
JBC_277_25233_25238
JBC_278_5163_5171
JBC_279_14819_14827
CirculationResearch_88_513_519
JBC_2004 Nov 12;279(46):47572-9
JBC_2004 Jun 11;279(24):25755-64
TheJournalOfImmunology_172_2803_2810.
CancerResearch_63_7777_7784
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Query Relevant articles Irrelevant articles
yes in vitro MBC_11_51_64
zap-70 in vitro  Blood_101_3534_3542 JCI_115_2287_2295
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